Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Tamsulosin can worsen sleep apnea in some patients.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Retinoids are effective for severe acne and psoriasis but can cause serious side effects and birth defects.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Certain medications can cause serious side effects, so it's important to report them.

New drug uses show promise but need more research.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Digital health technology improves health and medication adherence in kidney transplant patients.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Finasteride and dutasteride now have stronger warnings for psychiatric and sexual side effects.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.